First Joint Clinical Assessments for Medicinal Products Under EU Health Technology Assessment RegulationApril 21, 2025 The European Union has initiated its first joint clinical assessments for medicinal products under the Health Technology Assessment Regulation (EU 2021/2282), focusing on treatments for paediatric cancer and advanced skin cancer therapy.
